In addition, our previous study confirmed that the increased expression of DCLK1 in lung adenocarcinoma contributes to EGFR-TKI-acquired resistance, partly due to the maintenance of tumor cell stemness [27]. The gene discussed is EGFR; the disease is neoplasm.